NCT00050310
- Conditions
- Anthrax, Bacillaceae Infections, Bacillus Infections, +4 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Bacillaceae Infections
Explore clinical trials studying Bacillaceae Infections. Study availability and eligibility vary by location and protocol.
62 public trials
4 recruiting studies
Bacillaceae Infections trial results
NCT07201311
- Conditions
- Admission to Intensive Care, Anthrax, Bacillaceae Infections, +7 more
- Locations
-
- Sebastian Voicu Paris, France
Recruiting
Cigarette Filter Study
NCT07348679
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +9 more
- Locations
-
- Institute for Nicotine and Tobacco Studies New Brunswick, New Jersey, United States
NCT05471479
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +6 more
- Locations
-
- CHU de Québec - Université Laval Québec, Quebec, Canada
Not Yet Recruiting
SGLT2 Inhibitor Utilization Re-perfusion Therapy
NCT06858436
- Conditions
- Acute Ischemic Stroke From Large Vessel Occlusion, Anthrax, Bacillaceae Infections, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax
NCT07478471
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
NCT02177721
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +4 more
- Locations
-
Not specified
Not Yet Recruiting
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
NCT03569553
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +5 more
- Locations
-
Not specified
Not Yet Recruiting
Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
NCT03569514
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +3 more
- Locations
-
Not specified
Not Yet Recruiting
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
NCT07268612
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +6 more
- Locations
-
Not specified